GST NO. : 27AEZFS4094K1ZY
Pharmaceutical Injections
Leading Exporters, Wholesaler and Trader of Cytosar 100mg Cytarabine Injection and Zoldria Zoledronic Acid Injection from Thane.
| Business Type | Exporter, Supplier, Trader |
| Strength | 100mg |
| Dosage Form | Intravenous Injection |
| Type | Chemotherapy Drug |
| Certification | WHO-GMP Certified |
| Packaging | Box |
| Packaging Size | 10ml |
| Manufacturer | Pfizer Ltd |
| Active Ingredient | Cytarabine |
| Indicated For | AML, ALL, CML, And Other Leukemias |
| Patient Benefits | Effective Chemotherapy Agent For Blood Cancers |
Product Description
- Indicated For: AML, ALL, CML, and other leukemias
- Active Ingredient: Cytarabine 1000mg
- Mechanism of Action: Inhibits DNA synthesis, preventing cancer cell growth
- Dosage Form: Intravenous injection (1 vial per pack)
- Manufactured By: Pfizer Ltd (WHO-GMP certified)
- Patient Benefits: Effective chemotherapy agent for blood cancers
- Medical Supervision Required: Administered by healthcare professionals
- Cytosar 1000mg Injection contains Cytarabine (1000mg), a chemotherapy drug used in the treatment of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML). It works by interfering with the growth of cancer cells, slowing or stopping their spread in the body. Manufactured by Pfizer Ltd, Cytosar 1000mg is administered via intravenous (IV) injection under medical supervision. It is a crucial part of chemotherapy regimens and is often combined with other anti-cancer medications. Patients should be monitored for side effects, and dosage should be tailored based on medical advice.
| Business Type | Exporter, Supplier, Trader |
| Packaging Type | Box |
| Strength | 4mg |
| Indicated For | Osteoporosis, Paget's Disease, Bone Metastases |
| Active Ingredient | Zoledronic Acid |
| Dosage Form | Intravenous (IV) Injection |
| Benefits | Reduces Fracture Risks And Bone Loss |
| Administration | Given By A Healthcare Professional |
| Monitoring Required | Kidney Function And Calcium Levels |
Product Description
- Indicated For: Osteoporosis, Paget’s disease, bone metastases
- Active Ingredient: Zoledronic Acid 4mg
- Mechanism of Action: Inhibits bone resorption and strengthens bones
- Dosage Form: Intravenous (IV) injection
- Benefits: Reduces fracture risks and bone loss
- Administration: Given by a healthcare professional
- Monitoring Required: Kidney function and calcium levels
- Zoldria 4mg contains Zoledronic Acid (4mg), a bisphosphonate used to treat osteoporosis, Paget’s disease, and bone complications caused by cancer. It works by inhibiting bone breakdown, increasing bone density, and reducing fracture risks. This intravenous injection is commonly prescribed for postmenopausal women, individuals with osteoporosis, and cancer patients with bone metastases. Zoldria 4mg is administered under medical supervision, typically once a year or as recommended by a physician. Regular monitoring of kidney function and calcium levels is necessary to prevent complications. It is a trusted solution for managing bone health and preventing fractures in high-risk patients.a
